Qing-Shan Ji1, Bing Qi2, Yue-Chun Wen1, Lian Liu2, Xiao-Ling Guo3, Guo-Cheng Yu2, Jing-Xiang Zhong2. 1. Department of Ophthalmology, Affiliated Anhui Provincial Hospital of Anhui Medical University, Hefei 230001, Anhui Province, China. 2. Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou 510632, Guangdong Province, China. 3. Department of Cell Biology, the Cell Biology Institute of Jinan University, Guangzhou 510632, Guangdong Province, China.
Abstract
AIM: To investigate the association of lysyl oxidase-like 1 (LOXL1) single nucleotide polymorphisms (SNPs) with exfoliation syndrome (XFS)/exfoliation glaucoma (XFG). METHODS: Published manuscripts from PubMed and EMBASE were identified until May 2014. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for LOXL1 (rs1048661, rs2165241 and rs3825942) polymorphisms and the risk of XFS/XFG were estimated using random- or fixed- effect model. RESULTS: The three LOXL1 polymorphisms (rs1048661, rs3825942, and rs2165241) were associated with an increased risk for XFS/XFG among Caucasians, with OR 2.19(1.96-2.45), 8.8 (6.05-12.79) and 3.41 (3.11-3.73), respectively. On the contrast, the rs1048661 and rs2165241, but not rs3825942 polymorphism, have a potential protective effect on XFS/XFG in Asians, with OR 0.06 (0.02-0.18), 0.15 (0.09-0.25), respectively. CONCLUSION: There is strong evidence that LOXL1 polymorphisms are associated with XFS/XFG risk. The strength of risk might be ethnicity-dependent.
AIM: To investigate the association of lysyl oxidase-like 1 (LOXL1) single nucleotide polymorphisms (SNPs) with exfoliation syndrome (XFS)/exfoliation glaucoma (XFG). METHODS: Published manuscripts from PubMed and EMBASE were identified until May 2014. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for LOXL1 (rs1048661, rs2165241 and rs3825942) polymorphisms and the risk of XFS/XFG were estimated using random- or fixed- effect model. RESULTS: The three LOXL1 polymorphisms (rs1048661, rs3825942, and rs2165241) were associated with an increased risk for XFS/XFG among Caucasians, with OR 2.19(1.96-2.45), 8.8 (6.05-12.79) and 3.41 (3.11-3.73), respectively. On the contrast, the rs1048661 and rs2165241, but not rs3825942 polymorphism, have a potential protective effect on XFS/XFG in Asians, with OR 0.06 (0.02-0.18), 0.15 (0.09-0.25), respectively. CONCLUSION: There is strong evidence that LOXL1 polymorphisms are associated with XFS/XFG risk. The strength of risk might be ethnicity-dependent.
Authors: Haoyu Chen; Li Jia Chen; Mingzhi Zhang; Weifeng Gong; Pancy Oi Sin Tam; Dennis Shun Chiu Lam; Chi Pui Pang Journal: Mol Vis Date: 2010-02-06 Impact factor: 2.367
Authors: Khaled K Abu-Amero; Essam A Osman; Ahmed S Dewedar; Silke Schmidt; R Rand Allingham; Saleh A Al-Obeidan Journal: Mol Vis Date: 2010-12-16 Impact factor: 2.367
Authors: Burcu Kasım; Murat İrkeç; Mehmet Alikaşifoğlu; Mehmet Orhan; Mehmet Cem Mocan; Dilek Aktaş Journal: Mol Vis Date: 2013-01-28 Impact factor: 2.367
Authors: Jose A Aragon-Martin; Robert Ritch; Jeffrey Liebmann; Colm O'Brien; Karima Blaaow; Franco Mercieca; Anthony Spiteri; Caroline J Cobb; Karim F Damji; Ahti Tarkkanen; Tayebeh Rezaie; Anne H Child; Mansoor Sarfarazi Journal: Mol Vis Date: 2008-03-17 Impact factor: 2.367
Authors: Georg Mossböck; Wilfried Renner; Christoph Faschinger; Otto Schmut; Andreas Wedrich; Martin Weger Journal: Mol Vis Date: 2008-05-09 Impact factor: 2.367